Rigel Pharmaceuticals | 판매 매출 총 이익

주가
32.96
매일 변경
-1.66 -4.79%
매월
-5.69%
매년
49.28%
Q1 예상
33.68




판매 매출 총 이익 변화 날짜
Agenus USD 23.93M 2.79M 2025-03
Amgen USD 6.48B 307M 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Celldex Therapeutics USD 121K 609K 2025-12
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 195M 40M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
MacroGenics USD 61.25M 88.71M 2025-09
Neurocrine Biosciences USD 787.9M 7M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Veracyte USD 101.97M 10.69M 2025-12


Rigel Pharmaceuticals 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2026.